By 1 2 1 News Reporter
Chandigarh, 01st July:-- There is good news & new hope for those battling the dreaded disease -- Cancer. CanCure Clinics, that introduced an innovative anti cancer biotech medicine "Chinmanna" in February 2013, has had very encouraging and impressive clinical impressions of the drug, just after Four (4) month's, post launch. The results could be path-breaking in the medical fraternity's war against Cancer, as the therapy has proved very effective. The treatment's impact was shared with journalists by experts from CanCure Clinics.
According to Dr. Parminder Kaur, CEO, CanCure Clinics, "The therapy that the company has introduced in the Indian market is first of its kind and is known as "Cancer Immunotherapy" that acts at cellular level. Products that are being used at CanCure Clinics to treat cancer are all Hi-Tech Biotech products. It is proved beyond doubt from our lab investigations that patients who received this combination Chinmanna and Chemotherapy now have improved survival rates & QoL. The synergistic activity of combinations of cancer immunotherapy and chemotherapy is supported by clinical studies conducted by Meriyana International Biotech, Taiwan. Evidence clearly suggests that this chemo-immunotherapy can be effective in the treatment of cancer and may provide substantial clinical benefits for patients with advanced disease". Buoyed by this initial success, the company is announcing free consultation until 10th July for cancer patients intending to take a new road to beat cancer. On a different note, the company is also going to conduct clinical trial in HIV positive patients in the coming months for another promising product in the pipeline.She further stated that Moreover, there is no drug interaction and thus the medicine can be given safely along with Chemotherapy and/or Radiotherapy. When given together with Chemotherapy, it works as Chemo-immunotherapy which is a new concept in India.
Dr. Rahul Verma, Health Services Manger, CanCure Clinics indicated that the treatment protocol of"Chinmanna" was followed by eight patients with different forms of Cancers and Stages. The patients have shown remarkable improvement in both reduction of symptoms, medical parameters and Quality of Life. These difference before and post treatment was presented to media in form of concrete data like medical reports and internationally validated Quality of Life Questionnaires for cancer patients. These questionnaires are being followed in EU/USA so as to assess the treatment outcome on daily life of cancer patients, which is usually very burdensome at later stage, esp. after undergoing conventional treatment therapies.
No comments:
Post a Comment